Tiziana Life Sciences Ltd
NASDAQ:TLSA
Balance Sheet
Balance Sheet Decomposition
Tiziana Life Sciences Ltd
Tiziana Life Sciences Ltd
Balance Sheet
Tiziana Life Sciences Ltd
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
5
|
0
|
66
|
42
|
18
|
1
|
4
|
|
| Cash Equivalents |
5
|
0
|
66
|
42
|
18
|
1
|
4
|
|
| Total Receivables |
1
|
1
|
4
|
6
|
6
|
6
|
4
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
7
|
2
|
70
|
49
|
24
|
7
|
8
|
|
| PP&E Net |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
2
|
5
|
4
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
7
N/A
|
2
-65%
|
71
+2 849%
|
49
-31%
|
26
-46%
|
12
-54%
|
11
-7%
|
|
| Liabilities | ||||||||
| Accounts Payable |
4
|
4
|
3
|
4
|
5
|
4
|
6
|
|
| Accrued Liabilities |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
2
|
1
|
0
|
0
|
0
|
|
| Total Current Liabilities |
6
|
7
|
8
|
8
|
7
|
7
|
7
|
|
| Long-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
6
N/A
|
8
+24%
|
8
+4%
|
8
-9%
|
7
-8%
|
7
-4%
|
7
+11%
|
|
| Equity | ||||||||
| Common Stock |
5
|
5
|
8
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
38
|
48
|
72
|
24
|
8
|
8
|
18
|
|
| Additional Paid In Capital |
34
|
36
|
112
|
16
|
16
|
16
|
23
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
1
|
2
|
0
|
|
| Other Equity |
0
|
1
|
14
|
0
|
3
|
1
|
2
|
|
| Total Equity |
1
N/A
|
6
N/A
|
63
N/A
|
41
-34%
|
20
-53%
|
6
-72%
|
4
-29%
|
|
| Total Liabilities & Equity |
7
N/A
|
2
-65%
|
71
+2 849%
|
49
-31%
|
26
-46%
|
12
-54%
|
11
-7%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
68
|
68
|
97
|
102
|
102
|
103
|
111
|
|